MEDVi vs Noom: Which GLP-1 Program Is Actually Worth It in 2026?

If you're comparing MEDVi vs Noom for GLP-1 weight loss, here's the short version so you don't have to scroll through 8,000 words to get it:

That's the verdict. The rest of this page exists to prove it — with verified pricing, real patient results, honest downsides, and every follow-up question you'd otherwise go back and search for. We've done the research so you don't have to.

Disclosure: We have an affiliate relationship with MEDVi. Our comparison methodology is applied identically to both platforms. We include honest downsides for both because your trust matters more than any single commission. Full disclosure

MEDVi vs Noom at a Glance: The Comparison Table

Before we go deep, here's the side-by-side. We verified every number against the official pricing pages in February 2026. Where something is “provider-stated” versus independently verified, we've noted it.

Last verified: February 2026. Sources: medvi.org, noom.com/blog/weight-management/noom-cost/, consumeraffairs.com, trustpilot.com

Pick MEDVi If… Pick Noom Med If… Skip Both If…

If you read nothing else on this page, read this. It'll save you hours of comparison paralysis.

Pick MEDVi if you:

• Want the most direct path to GLP-1 medication — no app requirements, no daily lessons, no food logging homework
• Value simple, flat pricing where one number covers everything (medication, consultations, shipping, support)
• Want fast clinical responses at midnight when nausea hits (MEDVi's clinical team is available 24/7; Noom's clinician messaging has up to 36-hour response times)
• Are comfortable managing your own diet and exercise habits — or using a free app like MyFitnessPal for tracking
• Need affordable cash-pay GLP-1 access without insurance
• Prefer month-to-month billing over paying three months upfront
• Want to start fast — most patients get approved and receive medication within days, not weeks

Pick Noom Med if you:

• Want structured, psychology-based coaching alongside your medication — daily CBT lessons, food logging, habit-building tools, community support
• Believe the “why” behind your eating matters as much as the medication itself
• Have insurance that may cover brand-name GLP-1s like Wegovy or Zepbound (Noom's Telehealth plan helps navigate prior authorizations)
• Are interested in microdosing — Noom's Microdose GLP-1Rx program is one of the few options designed for lower doses with fewer side effects
• Want an app-based community of other people on the same journey

Skip both and talk to your doctor if you:

• Already have insurance that covers brand-name GLP-1s with a copay under $100/month
• Have complex medical conditions that need in-person monitoring
• Are pregnant, breastfeeding, or have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Wait — Are We Comparing MEDVi vs Noom Weight or MEDVi vs Noom Med?

This trips people up, and honestly, we don't blame anyone for being confused. Noom has multiple products under one brand name, and the pricing pages don't always make it obvious which one you're looking at.

Noom Weight is the original Noom — the psychology-based weight loss app with daily lessons, food logging, coaching, and no medication. It costs $17–70/month depending on your plan length. This is not what we're comparing to MEDVi. Noom Weight doesn't prescribe or ship GLP-1 medication.

Noom Med is the clinical layer that adds prescription weight loss medications on top of the Noom Weight experience. Under the Noom Med umbrella, there are four main medication-focused plans in 2026:

Noom also offers a Weight-Loss Pill plan (metformin, starting at $69) and the standalone Noom Weight app ($17–70/mo, no medication). Other meds like Contrave may be prescribed depending on eligibility.

The apples-to-apples comparison with MEDVi is Noom's GLP-1Rx Full Dose plan. Both include compounded semaglutide, both are cash-pay, and both ship medication to your door. That's what we're primarily comparing throughout this page.

When Noom's other plans are relevant — like the Microdose option or the Telehealth plan for insurance users — we'll call that out specifically.

The Real Cost: What You'll Actually Pay Over 6 and 12 Months

Intro prices are marketing. What matters is the number on month 3, month 6, and month 12. So we ran the math for the two most common scenarios.

Scenario 1: Compounded semaglutide injection, cash-pay

Scenario 2: If you're considering Noom's Microdose instead

Note: Noom Microdose bills $99 for the initial 4-week supply, then $597 every 12 weeks ($199/mo). Actual billing charges come in quarterly lumps, not monthly installments — so budget accordingly.

We'll be honest with you: On pure price, Noom is slightly cheaper. The full-dose plan saves you about $22/month versus MEDVi over a year. The Microdose plan is significantly cheaper — but it's also a lower dose, designed for people who want to minimize side effects rather than maximize weight loss speed.

But price isn't the whole story. Here's what that $22/month difference buys you with MEDVi:

• 24/7 clinical messaging with providers who respond in real-time, versus Noom's clinician messaging with up to 36-hour response times
• Month-to-month billing instead of quarterly upfront (Noom charges 3 months at once after the intro period — that's $837 in one hit for full-dose)
• Simpler cancellation — no documented pattern of billing complaints (Noom's BBB page notes a “high volume of complaints,” primarily about billing)
• Straightforward program — one price, one medication, clinical support. No app tiers to navigate

The question isn't really “which saves me $22/month?” It's “which model fits how I want to lose weight?”

If you'll genuinely use daily CBT lessons, food logging, and the coaching community — Noom's extra features justify the savings. If you want your medication and clinical support without the app overhead — MEDVi's simplicity and 24/7 access are worth the modest difference.

A note on that price jump after month 1

Both platforms have a discounted first month, and both jump significantly afterward. MEDVi goes from $179 to $299. Noom goes from $129 to $279. The jump is real for both — but both disclose it clearly on their pricing pages.

Here's the reframe that matters: Even at $299/month, MEDVi's compounded semaglutide costs a fraction of brand-name Wegovy, which lists at $1,349/month in the U.S. The same drug in Germany costs $137. In the UK, $92. You're not overpaying — you're accessing a medication that the U.S. healthcare system has made unreasonably expensive through other channels. See our full GLP-1 cost breakdown.

What Is MEDVi and How Does It Actually Work?

MEDVi is a telehealth clinic that does one thing and does it well: it connects you with licensed clinicians who can prescribe GLP-1 medications, then ships those medications directly to your door. No coaching app. No daily lessons. No food logging. Just medication, clinical oversight, and support.

Think of it like this: if Noom is a full-service restaurant with a 12-page menu, MEDVi is the place that makes three dishes but makes them exceptionally well.

How MEDVi works (4 steps):

MEDVi pricing — the full picture, no surprises

Note: MEDVi's terms state that medication charges may fluctuate depending on medication type, dosage, and pharmacy. Tirzepatide ongoing pricing may vary — confirm with MEDVi during your evaluation.

One price. Everything included. No separate “app fee.” No separate “coaching fee.” No quarterly billing surprises.

What real MEDVi patients are saying

We spent time going through verified reviews on ConsumerAffairs and Trustpilot — not the curated testimonials on MEDVi's own site. Here's what patterns we noticed:

The positive pattern (overwhelmingly dominant): Patients consistently praise the speed, the support quality, and the simplicity. More than 75% of reviews give MEDVi five stars, with customer service mentioned as a standout.

“MEDVi has been wonderful as a support system and medication provider. I've lost 25 pounds and feel amazing. The online support is convenient and the providers are mindful of the struggles associated with weight loss.”— Verified ConsumerAffairs reviewer, January 2026

“I started off scared and skeptical when I began my MEDVi journey. But I was pleasantly surprised by the helpful chat option to get all my questions answered. Ordering, refills, and provider check-ins have all gone smoothly. Down 30 lbs.”— Verified ConsumerAffairs reviewer, January 2026

“Dropping 27 lbs with MEDVi has been such a confidence builder. I'm more comfortable in my clothes, my routines feel easier, and I'm not fighting my body the way I used to.”— Verified ConsumerAffairs reviewer, January 2026

The negative pattern (small but real): A handful of reviews mention confusion about the billing cycle (MEDVi starts billing from your sign-up date, not your medication delivery date) and a few reported rescheduled appointments. MEDVi's support team actively responds to negative reviews on ConsumerAffairs, which tells us they're paying attention — but it's worth knowing going in.

Reviews are individual experiences. Platforms like ConsumerAffairs verify reviewer contact information but do not fact-check outcomes.

MEDVi trust credentials

• LegitScript certified — independently monitored for compliance with state and federal laws
• Pharmacy partners: Multiple U.S. certified pharmacies — MEDVi states they meet regularly with pharmacy partners to review medication testing and quality
• Medical network: OpenLoop Health — U.S.-licensed physicians who make all prescribing decisions independently
• Available in 49 states (all except North Dakota; some states require video visits)
• 100,000+ patients served (provider-stated)
• Results guarantee: Follow the program for 5+ months without weight loss → eligible for refund minus 25% consultation fee
• HSA/FSA eligible
• 93% of patients kept weight off over their first 6 months (MEDVi-stated, based on self-reported patient data)

What Is Noom Med and How Does It Actually Work?

Noom started in 2008 as a psychology-based weight loss app — no medication, just daily lessons rooted in cognitive behavioral therapy (CBT), food logging, coaching, and community support. It's helped millions of people, and the science behind behavior change is real.

Noom Med is the newer clinical extension that adds prescription weight loss medications — including GLP-1s — on top of that behavioral foundation. The idea is sound: pair the medication with the habit-building tools, and you get better long-term results than medication alone. Noom's own data on their Med page shows their members on GLP-1s lost 48% more weight in 6 months than people taking GLP-1 medication without behavioral support.

But here's where it gets complicated.

Noom Med's plan structure

Unlike MEDVi's straightforward pricing, Noom Med has four main medication-focused plans — and the differences between them are genuinely confusing. We already broke down the plan table above, but the key things to understand:

The cheapest plan ($69 first-month Telehealth) does NOT include medication. It gives you clinician access to prescribe brand-name GLP-1s, but you fill that prescription at your own pharmacy and pay whatever your insurance (or cash price) dictates. After the 30-day trial, it's $99/month billed quarterly. This is a good option if your insurance covers Wegovy or Zepbound — Noom helps navigate prior authorizations.

The GLP-1Rx Full Dose plan ($129 intro → $279/month) is the apples-to-apples comparison with MEDVi. Medication is included. It ships to you. It's cash-pay.

The Microdose plan ($99 intro → $199/month) is genuinely unique to Noom. It uses 25% or less of the standard GLP-1 dose, which Noom says results in 70% of members reporting zero side effects. Research presented at the 2025 European Congress on Obesity showed 16% average body weight loss at microdose levels of semaglutide over 64 weeks. If you're nervous about side effects, this is worth serious consideration — though it's only available through Noom.

Noom's genuine strengths

• Behavioral science backbone: 40+ peer-reviewed articles support Noom's approach. CBT-based habit change is backed by real evidence.
• Microdose option: Nobody else offers this specific program. If minimizing side effects is your top priority, Noom stands alone here.
• Taper-Off Guarantee: Complete 12 consecutive months of a Noom Med plan, maintain engagement (earning an average of 10+ NoomCoins per month), and if you still need help maintaining weight after tapering off medication, you can claim a free 12-month Noom Healthy Weight subscription (or equivalent credit toward a Noom Med plan). You must claim within 18 months of completing the program. It's an industry-first commitment to long-term outcomes.
• Insurance navigation: The Telehealth plan actively helps with prior authorizations for brand-name GLP-1s — genuinely useful if you have coverage.
• The app itself is well-designed. Daily lessons, food tracking with a color-coded system, workout library, progress tracking — it's a real product with real development behind it.

Noom's documented pain points

And we're not going to hide the problems either. These showed up consistently across BBB, Trustpilot, ConsumerAffairs, and Reddit:

Sources: bbb.org/noom, trustpilot.com/review/noom.com, consumeraffairs.com/health/noom.html

Side Effects: Are They Different Between MEDVi and Noom Med?

No. Full stop. The side effects come from the medication, not the platform. Both MEDVi and Noom Med prescribe the same class of drugs — GLP-1 receptor agonists, including compounded semaglutide and compounded tirzepatide. The expected side effect profile is similar regardless of which platform prescribes it. See our full guide to GLP-1 side effects.

Common GLP-1 side effects

Per the FDA prescribing information for semaglutide (Wegovy) and tirzepatide (Zepbound):

• Nausea — the most common, especially in the first 4–8 weeks as your body adjusts
• Diarrhea or constipation
• Vomiting
• Stomach pain or bloating
• Headache
• Fatigue
• Decreased appetite (this is partly the point)

Most side effects are dose-dependent and temporary. They typically improve as your body adjusts, especially with proper titration (starting low and gradually increasing). Learn how to take GLP-1 safely.

Serious risks and contraindications

This isn't optional reading:

• Boxed warning (both semaglutide and tirzepatide): In animal studies, these drugs caused thyroid C-cell tumors, including medullary thyroid carcinoma. They are contraindicated in people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Pancreatitis risk: Cases have been reported. Seek medical attention for severe abdominal pain.
• Gallbladder problems: GLP-1s may increase the risk of gallstones.
• Kidney injury: Primarily from dehydration due to GI side effects.

Sources: FDA prescribing information — Wegovy (semaglutide) label, Zepbound (tirzepatide) label

Where the platform DOES matter for side effects

MEDVi's 24/7 clinical messaging means when nausea hits at 11pm — and it will, especially in the first few weeks — you can message a provider and get guidance right then, not up to 36 hours later. Side effects feel less scary when someone's actually available to help you through them in real time. This isn't a minor point. Side effect management is the number one reason people stop GLP-1 treatment. Having real-time access to clinical support means you're more likely to push through the adjustment period instead of quietly quitting.

Noom's Microdose program takes a different approach: rather than managing side effects after the fact, it tries to prevent them by using a significantly lower dose (25% or less of standard). Noom reports 70% of microdose members experience zero side effects. The tradeoff is potentially slower weight loss — though research suggests microdose results can still be significant when paired with behavior change.

FDA safety notes about compounded GLP-1s

Both MEDVi and Noom Med offer compounded GLP-1s — and you should know what that means for safety. Compounded medications are produced by compounding pharmacies and are intended to contain the same active ingredient as brand-name drugs. They are not FDA-approved — meaning they haven't undergone the same FDA review for safety, efficacy, or quality as Ozempic, Wegovy, Zepbound, or Mounjaro.

What this means practically: Choose a provider that works with established, U.S.-certified compounding pharmacies. MEDVi states they partner with multiple U.S. certified pharmacies and meet regularly with them to review medication testing. Noom states their partners are “USP-compliant and state-regulated.” Both allow you to request a Certificate of Analysis for your medication batch. See our guide to choosing safe compounded semaglutide.

Sources: fda.gov — “FDA's Concerns About Unapproved GLP-1 Drugs Used for Weight Loss,” FDA dosing error alert for compounded semaglutide

Is MEDVi Legit? Is Noom Med Legit? How to Verify Both in 5 Minutes

We understand the anxiety. You're about to hand your health information and credit card to a telehealth platform you found online. “Is this legit?” is probably the most important question on this entire page. Here's how to verify both — and what we found when we did.

MEDVi verification

Noom Med verification

Our take on the trust question

Both are legitimate companies with real medical oversight. Neither is a scam. But the experience of trusting each one is different. Both score similarly on Trustpilot (4.5/5), but Noom's review profile reflects a wider range of experiences given its much larger user base. Noom has a longer track record and more scientific backing — but also significantly more documented billing friction.

If “will they charge me after I cancel?” keeps you up at night, MEDVi's month-to-month model with a cleaner complaint history is the safer bet.

How Fast Do You Get Your Medication?

Speed matters when you've finally decided to start. Here's the realistic timeline for each.

MEDVi timeline

Noom Med timeline (GLP-1Rx plan)

For the Telehealth (branded meds) plan, add time for prior authorization with your insurance — which Noom says can take up to 14 days, with appeals taking up to 90 days.

MEDVi is generally faster because it skips the video visit requirement in most states and uses a streamlined asynchronous review process. If getting started quickly is important to you — and for most people who've finally made the decision, it is — this matters.

Cancellation and Refunds: Read This Before You Sign Up for Either

This is the section that saves people money and frustration. We wish more comparison pages covered it honestly.

How to cancel MEDVi

MEDVi is month-to-month. Cancel anytime by contacting their support team. The key detail: you need to cancel at least 72 hours before your next billing date to avoid being charged for the next month. If medication has already been ordered for the upcoming cycle, you generally can't get a refund for that order.

The smart move: Set a phone reminder 5 days before your billing date if you're thinking about canceling. Screenshot your cancellation confirmation.

Refund policy highlights:

• If you're medically disqualified during evaluation, you get a full refund
• If you've been on the program 5+ months without weight loss results, you may qualify for a refund (minus 25% for consultation fees)
• Prescription products that have shipped are non-refundable

The cancellation window is strict. But here's the full picture: MEDVi doesn't lock you into quarterly billing, doesn't auto-renew for 3 months at a time, and has a dramatically lower volume of billing complaints than Noom on every review platform. The 72-hour window is a minor friction point in an otherwise clean billing model.

How to cancel Noom Med

Noom's cancellation is where things get frustrating for some users. You can cancel anytime through the app settings. But after your intro month, you're billed quarterly upfront. If you cancel mid-quarter, you don't get a partial refund for the remaining months. That's up to two months of payments you can't recover.

Documented issues to know about:

• Multiple BBB and Trustpilot reviewers report being charged after they believed they'd canceled
• Some users reported that completing a “check-in form” with their doctor inadvertently triggered automatic renewal and a charge of $600+
• Noom's BBB page receives enough complaints that they only publish 1 out of every 5

The smart move: If you try Noom Med, screenshot your subscription status before and after canceling. Save the confirmation email. And don't fill out any “check-in” forms if you're planning to cancel.

We want to be fair: Noom is a legitimate company and many users have smooth cancellation experiences. But the pattern of billing complaints is documented across multiple independent platforms, and you should go in with your eyes open.

Can I Use Insurance, FSA, or HSA?

MEDVi

• Insurance: No. MEDVi is cash-pay only for both consultations and compounded medications. If you choose brand-name options (starting at $1,999/month), you may submit a claim to your insurer for potential reimbursement.
• HSA/FSA: Yes — MEDVi accepts HSA and FSA cards, though coverage isn't guaranteed by every plan administrator.

Noom Med

• Insurance: Depends on the plan. The Telehealth plan ($69 first month, then $99/month) is specifically designed for people with insurance — your clinician prescribes brand-name GLP-1s, helps with prior authorizations, and you fill at your local pharmacy with insurance coverage. The GLP-1Rx plans (compounded) are cash-pay.
• HSA/FSA: Noom mentions FSA/HSA eligibility on their pages but notes it depends on your specific plan administrator.

Bottom line: If you have good insurance that covers GLP-1s, Noom's Telehealth plan is worth considering — it's the cheaper path ($69 for 30 days, then $99/month + insurance copay). If you're cash-pay, both MEDVi and Noom's GLP-1Rx plans are comparable, with MEDVi offering simpler billing. Full GLP-1 cost guide with and without insurance.

Do You Need Labs? And Will They Cost Extra?

MEDVi

Labs are covered at no cost as part of your membership. However, labs are required after your second month for dosage increases (moving from Level 2 to Level 3) and become mandatory after your third month to continue treatment — without completing labs before your fourth prescription, MEDVi cannot continue your care. MEDVi partners with LabQuest, LabCorp, and Bioreference (for NY/NJ/RI residents). You can also use existing lab results if they're from within the last 24 months.

Noom Med

Labs are included in most states and most plans. Noom uses Quest or Labcorp for baseline biomarker testing. Exceptions: if you live in New York, New Jersey, or Rhode Island, insurance is required for lab work and additional costs may apply. Some plans include an initial biomarker kit as part of onboarding.

Neither platform should surprise you with a lab bill — both cover lab costs. But with MEDVi, be aware that labs become mandatory after month 3 and will delay your treatment if not completed. Ask specifically during your evaluation so you know the timeline.

MEDVi vs Noom Reviews: What Patterns Show Up Across Thousands of Reviews

We read through hundreds of reviews on ConsumerAffairs, Trustpilot, BBB, and Reddit for both platforms. Here's what the patterns — not individual cherry-picked quotes — actually show.

MEDVi review patterns (8,100+ Trustpilot reviews, 4.5/5)

What people consistently praise:

• Speed of getting started and receiving medication
• Quality and responsiveness of customer support (specific names like “Ana,” “Arik,” “Tonya” come up repeatedly — a good sign that real humans are providing consistent care)
• Simplicity of the process — “no-nonsense” is a common descriptor
• Real weight loss results — 20–30 lb losses over 5–6 months are commonly reported

What people occasionally complain about:

• Billing cycle confusion (charges start from sign-up date, not delivery date)
• Some appointment rescheduling
• One negative reviewer reported less than 4 lbs lost in 6 weeks and said the money-back guarantee wasn't honored — MEDVi's support team responded publicly and offered to resolve it

Noom review patterns (65,000+ Trustpilot reviews, 4.5/5)

What people consistently praise:

• The app content itself — daily lessons, psychological insights, the “aha moments” about eating habits
• Feeling supported and educated, not just medicated
• Some excellent individual clinician experiences
• Real weight loss results when people stick with the program

What people consistently complain about:

• Billing. Billing. Billing. This dominates negative reviews across every platform.
• Generic coaching responses that feel automated
• Difficulty reaching support for medication issues
• Expired medication being shipped after subscription changes
• Food logging being tedious over time

How Much Weight Can You Actually Expect to Lose?

We want to set realistic expectations because exaggerated promises are exactly what makes people distrust this entire space.

What the clinical research shows

The landmark STEP trials for semaglutide (the active ingredient in both MEDVi and Noom's compounded options) showed:

• Average of ~15% body weight loss over 68 weeks at the 2.4mg maintenance dose
• For a 220 lb person, that's roughly 33 lbs
• Results varied widely — some participants lost significantly more, some less
• Weight loss was most rapid in the first 6 months, then plateaued

For tirzepatide (SURMOUNT trials):

• Average of ~21% body weight loss over 72 weeks at the highest dose
• For a 220 lb person, that's roughly 46 lbs

What real patients on these platforms report

• MEDVi patients commonly report 20–30 lbs lost in 5–6 months. Several reviews mention specific numbers: 25 lbs, 26 lbs in 6.5 months, 27 lbs, 28 lbs, 30 lbs.
• Noom reports their members achieve 10% body weight loss by month 4 at twice the rate compared to non-engaged users.
• Noom's microdose data: Members lose up to 17 lbs in 60 days (top 25th percentile; average was 13 lbs).

The honest truth

The medication class is the same. Both MEDVi and Noom prescribe compounded semaglutide from the GLP-1 receptor agonist class. The difference in your results will come down to:

1. Consistency — do you take it regularly without gaps?
2. Side effect management — do you have support to push through the adjustment period instead of quitting?
3. Lifestyle changes — medication reduces appetite, but what you eat and how you move still matters
4. Dose titration — is your provider adjusting your dose appropriately?

MEDVi's 24/7 clinical messaging directly addresses #2 and #4 — you get real-time responses from providers, not 36-hour waits. Noom's behavioral platform directly addresses #3. Both can help with #1. Pick the one that matches your weak point.

The Support Difference: What You Actually Get Day-to-Day

This is the section where “features on a comparison table” turn into “what my Tuesday actually looks like.”

MEDVi: Clinical support without the app homework

Your daily experience with MEDVi is... minimal, and that's by design. You take your medication as prescribed. If you have questions, concerns, or side effects, you message your care team — and they respond, any time of day or night.

You'll have regular check-ins (monthly coaching sessions are part of the program), dosage adjustments as your body responds, and access to a metabolic report. But between check-ins, MEDVi doesn't require daily engagement with an app.

Who this works for: People who are self-directed. You already know how to eat better and move more — you just needed the biological help that GLP-1s provide. You don't want homework. You want medication and a safety net.

Noom Med: Full coaching ecosystem with clinical integration

Your daily experience with Noom Med is app-centered. You'll get:

• Daily psychology-based lessons (~10 minutes)
• Food logging with Noom's color-coded system
• Step and exercise tracking
• Access to coaches (AI and human)
• Community forums with other members
• GLP-1 Companion tools (protein tracking, Muscle Defense workouts, side-effect guides)
• Regular clinician check-ins for medication management

Who this works for: People who want structure and accountability. You want someone to help you understand why you eat the way you do, not just suppress your appetite. You thrive with daily engagement and community motivation.

The uncomfortable truth about coaching

We'll say what most comparison pages won't: most people don't use coaching apps long-term. The dropout curve for health apps is steep — excitement in week one, engagement dropping by month two, abandoned by month four. This isn't a knock on Noom specifically; it's a pattern across every health app ever studied.

If you're the kind of person who keeps streaks, logs meals consistently, and genuinely engages with daily lessons for months on end — Noom's behavioral platform is a real differentiator that justifies the price.

If you're honest with yourself and know that app will be forgotten by week six — you're paying for features you'll never use. MEDVi's simpler model respects that reality.

State Availability: Where Each Program Works

If you're in Alabama: MEDVi is available (injections only). Noom Med is not. If you're in Virginia: MEDVi is available. Noom Med is not. If you're in North Dakota: Noom Med is available. MEDVi is not.

For everyone else: both platforms are accessible. Check your GLP-1 eligibility.

Brand-Name vs Compounded GLP-1s: What You Need to Know

Both MEDVi and Noom Med primarily offer compounded GLP-1 medications on their cash-pay plans. If you're considering either platform, you need to understand what that means.

Brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) are manufactured by Novo Nordisk and Eli Lilly. They're FDA-approved, meaning they've undergone rigorous clinical trials for safety, efficacy, and manufacturing quality. They're also expensive — Wegovy lists at $1,349/month in the U.S.

Compounded GLP-1s are pharmacy-prepared formulations produced by compounding pharmacies. They are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality — they haven't undergone the same review process. The FDA states that compounded drugs should only be used when a patient's medical needs cannot be met by an FDA-approved drug, or the FDA-approved drug is not commercially available.

Why this matters:

• Compounded medications can vary in formulation, concentration, and quality from one pharmacy to another
• The FDA has warned that some compounded semaglutide products may use salt forms (semaglutide sodium or semaglutide acetate) that are different active ingredients than those in FDA-approved drugs — the FDA says these “have not been shown to be safe and effective”
• The FDA has issued specific alerts about dosing errors with compounded semaglutide (concentration confusion between mg and mg/mL that led to hospitalizations)
• The FDA has warned about fraudulent compounded products with false labels or incorrect ingredients
• The FDA has signaled intent to restrict mass-marketed compounded GLP-1s

What you can do to protect yourself:

1. Choose a provider that works with established, U.S.-certified compounding pharmacies and can provide documentation of their pharmacy partnerships
2. Request a Certificate of Analysis (COA) for your medication batch
3. Verify the pharmacy is 503A or 503B registered
4. Confirm that the semaglutide base form (not salt forms like semaglutide sodium or acetate) is being used
5. Report any medication that looks different from previous batches or arrives without proper labeling

Sources: fda.gov — “FDA's Concerns About Unapproved GLP-1 Drugs,” FDA dosing error alert, FDA action against non-FDA-approved compounded GLP-1 drugs

Best compounded semaglutide providers · Best compounded tirzepatide providers

If Neither MEDVi Nor Noom Fits, Here's What to Do Instead

Not everyone needs a telehealth GLP-1 platform. Here are the honest alternatives:

How We Compared MEDVi and Noom Med (Our Methodology)

Transparency about how we evaluated these platforms is part of the trust equation. Here's exactly what we did:

• Pricing verification: All pricing was checked against official websites (medvi.org and noom.com) in February 2026. We calculated real 6-month and 12-month costs using ongoing rates, not just introductory prices.
• Patient review analysis: We analyzed reviews from ConsumerAffairs, Trustpilot, BBB, and Reddit to identify patterns. We prioritized verified reviews from 2025–2026 and looked for themes across hundreds of data points, not cherry-picked quotes.
• Feature-by-feature comparison: We evaluated both platforms across 15+ standardized criteria: pricing structure, medication options, support accessibility, state availability, billing practices, cancellation friction, pharmacy transparency, clinical oversight model, and more.
• Source verification: All clinical claims cite FDA prescribing information, peer-reviewed research, or official company disclosures. Where claims are provider-stated (not independently verified), we label them as such.

What we scored and how:

Disclosure: We have an affiliate relationship with MEDVi. Our methodology was developed before we established any affiliate relationships and is applied identically to every platform we review. We include honest downsides for all platforms because your trust is worth more than any single commission. Full disclosure.

Update schedule: This comparison is reviewed and updated monthly. Pricing and availability data is reverified against official sources at each update.

FAQ: MEDVi vs Noom — Quick Answers

My Final Recommendation

We've spent weeks researching these two platforms — reading hundreds of reviews, verifying pricing against official sources, analyzing complaint patterns across BBB, Trustpilot, and ConsumerAffairs, and mapping every plan tier and pricing variant.

Here's where we landed:

Sources and Citations

All claims in this article are sourced from the following:

• FDA prescribing information: Wegovy (semaglutide) — accessdata.fda.gov; Zepbound (tirzepatide) — accessdata.fda.gov
• FDA safety alerts: “FDA's Concerns About Unapproved GLP-1 Drugs Used for Weight Loss” — fda.gov; FDA dosing error alert for compounded semaglutide — fda.gov; FDA action against non-FDA-approved compounded GLP-1 drugs — fda.gov
• MEDVi official: medvi.org (pricing, program details, refund policy)
• Noom official: noom.com/blog/weight-management/noom-cost/ (pricing); noom.com/med/ (program details); noom.com/med/glp1-microdose/ (Microdose program)
• Patient reviews: consumeraffairs.com/health/medvi.html; consumeraffairs.com/health/noom.html; trustpilot.com/review/medvi.org; trustpilot.com/review/noom.com
• BBB: bbb.org — Noom, Inc. business profile and customer reviews
• Clinical research: STEP trials (semaglutide); SURMOUNT trials (tirzepatide); European Congress on Obesity 2025 microdose data; Noom published member data

This article was last updated in February 2026. Pricing and availability are verified against official sources monthly.